Silent coronary artery disease in type 2 diabetes mellitus: the role of Lipoprotein(a), homocysteine and apo(a) polymorphism

Gazzaruso, Carmine; Garzaniti, Adriana; Giordanetti, Stefano; Falcone, Colomba; Fratino, Pietro
January 2002
Cardiovascular Diabetology;2002, Vol. 1, p5
Academic Journal
Background: There is little data on the relationship between novel cardiovascular risk factors and silent coronary artery disease (CAD) in diabetic patients. We investigated whether Lipoprotein(a), homocysteine and apolipoprotein(a) polymorphism are associated with angiographically assessed asymptomatic coronary artery disease (CAD) in diabetic patients. Methods: 1,971 type 2 diabetic patients without clinical signs of cardiovascular diseases and with a negative history of CAD were consecutively evaluated. Among them, 179 patients showed electrocardiographic abnormalities suggestive of ischemia or previous asymptomatic myocardial infarction. These 179 patients were subjected to a non-invasive test for CAD (ECG stress testing and/or scintigraphy). Among patients with a highly positive stress testing (n = 19) or a positive scintigraphy (n = 74), 75 showed an angiographically documented CAD (CAD group). Seventy-five patients without CAD (NO CAD group) were matched by age, sex and duration of diabetes to CAD patients. In NO CAD patients an exercise ECG test, a 48-hour ambulatory ECG and a stress echocardiogram were negative for CAD. Results: Lipoprotein(a) levels (22.0 � 18.9 versus 16.0 � 19.4 mg/dl; p < 0.05), homocysteine levels (13.6 � 6.6 versus 11.4 � 4.9 mmol/l; p < 0.05) and the percentage of subjects with at least one small apolipoprotein(a) isoform (70.7% versus 29.3%; p < 0.0001) were higher in CAD than NO CAD group. Logistic regression analysis showed that apolipoprotein(a) polymorphism (OR:8.65; 95%CI:3.05-24.55), microalbuminuria (OR:6.16; 95%CI:2.21-17.18), smoking (OR:2.53; 95%CI:1.05-6.08), HDL (OR:3.16; 95%CI:1.28-7.81), homocysteine (OR:2.25; 95%CI:1.14-4.43) and Lipoprotein(a) (OR:2.62; 95%CI:1.01-6.79) were independent predictors of asymptomatic CAD. Conclusions: The present investigation shows an independent association of Lipoprotein(a), homocysteine and apo(a) polymorphism with silent CAD. Other studies are needed to establish whether these parameters are suitable for CAD screening in diabetic patients.


Related Articles

  • Fasting, non-fasting glucose and HDL dysfunction in risk of pre-diabetes, diabetes, and coronary disease in non-diabetic adults. Onat, Altan; Can, Günay; Çiçek, Gökhan; Ayhan, Erkan; Doğan, Yüksel; Kaya, Hasan // Acta Diabetologica;Aug2013, Vol. 50 Issue 4, p519 

    We determined in non-diabetic persons the risk of fasting and non-fasting glucose levels for pre-diabetes, diabetes, and coronary heart disease (CHD), including the roles of serum C-reactive protein (CRP) and HDL cholesterol, and delineated risk profiles of the pre-diabetic states. Over 7¼...

  • Association of hypertension with small, dense low-density lipoprotein in patients without metabolic syndrome. Kim, Y K; Seo, H S; Lee, E M; Na, J O; Choi, C U; Lim, H E; Kim, E J; Rha, S-W; Park, C G; Oh, D J // Journal of Human Hypertension;Nov2012, Vol. 26 Issue 11, p670 

    A higher proportion of small, dense low-density lipoprotein (sdLDL) is known to be associated with a high prevalence of cardiovascular disease in association with metabolic syndrome (MS). Hypertension (HTN) is one of the known risk factors for MS. However, whether HTN is associated with sdLDL in...

  • Screening for coronary heart disease and diabetes risk in a dental setting. Kalladka, Mythili; Greenberg, Barbara; Padmashree, Shreenivasa; Venkateshaiah, Nagathihally; Yalsangi, Shilpa; Raghunandan, Bangalore; Glick, Michael // International Journal of Public Health;Jun2014, Vol. 59 Issue 3, p485 

    Objectives: Diabetes mellitus (DM) and heart disease, among the most prevalent chronic conditions worldwide, are increasing among younger adults who are unaware of their risk status. Previous studies in the United States have shown the efficacy of screening for risk of heart disease and diabetes...

  • Diabetes has a greater effect on mortality in women with CHD.  // Geriatrics;Dec93, Vol. 48 Issue 12, p58 

    Reports on the findings of a study regarding the effects of diabetes on patients with coronary heart disease. `Sex differences in the impact of coexistent diabetes on survival in patients with coronary heart disease,' by Y Liao, RS Cooper, JK Ghali, et al.

  • Agreement between Framingham Risk Score and United Kingdom Prospective Diabetes Study Risk Engine in Identifying High Coronary Heart Disease Risk in North Indian Population. Bansal, Dipika; Nayakallu, Ramya S. R.; Gudala, Kapil; Vyamasuni, Rajavikram; Bhansali, Anil // Diabetes & Metabolism Journal;Aug2015, Vol. 39 Issue 4, p321 

    Background: The aim of the study is to evaluate the concurrence between Framingham Risk score (FRS) and United Kingdom Prospective Diabetes Study (UKPDS) risk engine in identifying coronary heart disease (CHD) risk in newly detected diabetes mellitus patients and to explore the characteristics...

  • Lung Function and Risk of Type 2 Diabetes and Fatal and Nonfatal Major Coronary Heart Disease Events: Possible Associations With Inflammation. WANNAMETHEE, S. GOYA; SHAPER, A. GERALD; RUMLEY, ANN; SATTAR, NAVEED; WHINCUP, PETER H.; THOMAS, MARY C.; LOWE, GORDON D. // Diabetes Care;Sep2010, Vol. 33 Issue 9, p1990 

    OBJECTIVE -- We prospectively examined the relationship between lung function and risk of type-2 diabetes and fatal and nonfatal coronary heart disease (CHD) events and investigated the hypothesis that inflammation may underlie these associations. RESEARCH DESIGN AND METHODS-- A prospective...

  • Association of Cholesterol-rich Lipoproteins with Coronary Artery Disease in Subjects Who Referred to Yazd Cardiovascular Research Center for Coronary Angiography. Jalali-knabadi, B. A.; Mozaffari-khosravi, H.; Rafiei, M.; Ghoreishian, S. M.; Darabi, F. // Pakistan Journal of Biological Sciences;2006, Vol. 9 Issue 15, p2777 

    Coronary Artery Disease (CAD) is the leading cause of death in many populations, including Iranians. The best way to control CAD, is to identify and modify more effective local risk factors. The aim of this study was to determine and comparison of lipids, lipoproteins and lipoprotein (a) [Lp...

  • Statins: Is There an Increased Risk of Diabetes? Kolich, Meghan N.; Howard, Patricia A. // Hospital Pharmacy;Jul2012, Vol. 47 Issue 7, p513 

    The article discusses the benefits of Statins, the most widely used drug class for the management of dyslipidemia. A study conducted using data from the Women's Health Initiative (WHI) and evaluated the potential for increased risk of diabetes with Statin use in postmenopausal women. The US Food...

  • An apolipoprotein protector. P.F.C. // Cortlandt Forum;09/25/97, Vol. 10 Issue 9, p139 

    Reports that the major apolipoprotein constituent of high density lipoproteins (HDL) is cholesterol apo A-1, considered to have an inverse relationship to coronary artery disease. Discovery of mutant form of apo A-1 in people with low levels of HDL; Lack of clarity on mechanism through which the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics